NCT02879123 Early Neurological Clinical Recovery, 3 Months After Endovascular Treatment of an Acute Ischemic Stroke
| NCT ID | NCT02879123 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fondation Ophtalmologique Adolphe de Rothschild |
| Condition | Stroke, Acute |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2015-11-12 |
| Primary Completion | 2030-11-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2015-11-12 with a primary completion date of 2030-11-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This trial aims at collecting standardized data concerning the early neurological clinical recovery of patients, 3 months after endovascular treatment of an acute ischemic stroke. Although this outcome is a major issue of patients' prognosis, it is rarely collected at this stage of their follow-up.
Eligibility Criteria
Inclusion Criteria: * acute ischemic stroke * endovascular treatment Exclusion Criteria: * none
Contact & Investigator
Raphaël Blanc, MD
PRINCIPAL INVESTIGATOR
Fondation Ophtalmologique Adolphe de Rothschild
Frequently Asked Questions
Who can join the NCT02879123 clinical trial?
This trial is open to participants of all sexes, studying Stroke, Acute. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02879123 currently recruiting?
Yes, NCT02879123 is actively recruiting participants. Contact the research team at rblanc@for.paris for enrollment information.
Where is the NCT02879123 trial being conducted?
This trial is being conducted at Paris, France.
Who is sponsoring the NCT02879123 clinical trial?
NCT02879123 is sponsored by Fondation Ophtalmologique Adolphe de Rothschild. The principal investigator is Raphaël Blanc, MD at Fondation Ophtalmologique Adolphe de Rothschild. The trial plans to enroll 5,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.